Michael Sidler
Founder at Redalpine Venture Partners AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vincent Forster | M | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | 9 years |
| Philipp Spycher | M | - |
Araris Biotech AG
 Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | 5 years |
| Dominik Escher | M | - |
Araris Biotech AG
Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland.
University of Zurich
| 13 years |
| Dragan Grabulovski | M | - |
Araris Biotech AG
Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | 5 years |
| Meriam Kabbaj | M | 50 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | 9 years |
| Nadine Geiser | M | - |
Redalpine Venture Partners AG
 Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 5 years |
| Mark J. Fitzpatrick | M | 61 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Isabella Attinger-Toller | M | - |
Araris Biotech AG
Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | 5 years |
| Peter Niederhauser | M | 60 |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 18 years |
| Bettina Curtze | F | 47 |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 1 years |
| Dmitry Kuzmin | M | - |
Araris Biotech AG
Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | 4 years |
| Joseph Bernardo | M | - |
Lunaphore Technologies SA
 Lunaphore Technologies SA BiotechnologyHealth Technology Lunaphore Technologies SA develops tissue diagnostics solutions. Its products include in vitro diagnostics, automated staining instruments, and consumables. The company was founded by Ata Tuna Ciftlik, Diego Gabriel Dupouy, and D?borah Heintze in April 2014 and is headquartered in Tolochenaz, Switzerland. | 5 years |
| Daniel Dillinger | M | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 7 years |
| Marc Friedrich Luebke | M | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 3 years |
| Carlo Egle | M | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 6 years |
| Sebastian Becker | M | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 6 years |
| Michael Isima | M | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 4 years |
| Aleksandra Laska | F | 37 |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 4 years |
| Andreas Plückthun | M | 65 |
University of Zurich
| 31 years |
| Oliver Pabst | M | 58 |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 2 years |
| Hanspeter Richard | M | - |
MedMira Holding AG
 MedMira Holding AG Medical/Nursing ServicesHealth Services MedMira Holding AG operates as a holding company with interests in developing and manufacturing medical diagnostics and technologies. The firm provides medical progress to customers from all over the world while combining the quality with economical sustainability. The company was founded on December 22, 2008 and is headquartered in Zug, Switzerland. | - |
| Desiree Reimann | F | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 10 years |
| Harald Nieder | M | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 10 years |
| Christian Surber | M | - |
MedMira Holding AG
MedMira Holding AG Medical/Nursing ServicesHealth Services MedMira Holding AG operates as a holding company with interests in developing and manufacturing medical diagnostics and technologies. The firm provides medical progress to customers from all over the world while combining the quality with economical sustainability. The company was founded on December 22, 2008 and is headquartered in Zug, Switzerland. | - |
| Urs Meile | M | - |
MedMira Holding AG
MedMira Holding AG Medical/Nursing ServicesHealth Services MedMira Holding AG operates as a holding company with interests in developing and manufacturing medical diagnostics and technologies. The firm provides medical progress to customers from all over the world while combining the quality with economical sustainability. The company was founded on December 22, 2008 and is headquartered in Zug, Switzerland. | - |
| Patrick Griss | M | - |
Lunaphore Technologies SA
Lunaphore Technologies SA BiotechnologyHealth Technology Lunaphore Technologies SA develops tissue diagnostics solutions. Its products include in vitro diagnostics, automated staining instruments, and consumables. The company was founded by Ata Tuna Ciftlik, Diego Gabriel Dupouy, and D?borah Heintze in April 2014 and is headquartered in Tolochenaz, Switzerland. | 6 years |
| Christopher R. Seaton | M | - |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Hans Wehrli | M | 71 |
University of Zurich
| 31 years |
| Peter Nicklin | M | 61 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Hans Caspar von der Crone | M | 67 |
University of Zurich
| 27 years |
| Robert Schier | M | - |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Arnd Kaltofen-Ehmann | M | 64 |
Araris Biotech AG
Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | 4 years |
| Hermes Chan | M | - |
MedMira Holding AG
MedMira Holding AG Medical/Nursing ServicesHealth Services MedMira Holding AG operates as a holding company with interests in developing and manufacturing medical diagnostics and technologies. The firm provides medical progress to customers from all over the world while combining the quality with economical sustainability. The company was founded on December 22, 2008 and is headquartered in Zug, Switzerland. | - |
| Matthias Weber | M | - |
Lunaphore Technologies SA
Lunaphore Technologies SA BiotechnologyHealth Technology Lunaphore Technologies SA develops tissue diagnostics solutions. Its products include in vitro diagnostics, automated staining instruments, and consumables. The company was founded by Ata Tuna Ciftlik, Diego Gabriel Dupouy, and D?borah Heintze in April 2014 and is headquartered in Tolochenaz, Switzerland. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rolf M. Zinkernagel | M | 80 |
University of Zurich
| 16 years |
| Reto Suter | M | 53 |
University of Zurich
| 8 years |
| Thomas Gottstein | M | 60 |
University of Zurich
| 8 years |
| Rene Dittrich | M | 52 |
University of Zurich
| 6 years |
| Thomas Meier | M | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | 4 years |
| Mariel Hoch | M | 51 |
University of Zurich
| 14 years |
| Serena Liotti | F | - |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | - |
| Philippe Weber | M | 59 |
University of Zurich
| 5 years |
| Daniel von Stockar | M | - |
University of Zurich
| 5 years |
| Gabriela Maria Payer | M | 61 |
University of Zurich
| 7 years |
| Thomas Meier | M | - |
University of Zurich
| 6 years |
| Iris Bohnet Zürcher | M | 58 |
University of Zurich
| 5 years |
| Judith Bischof | M | 50 |
University of Zurich
| 6 years |
| Teodoro D. Cocca | M | 51 |
University of Zurich
| 7 years |
| Alexander Gut | M | 61 |
University of Zurich
| 6 years |
| Daniel Schmucki | M | 56 |
University of Zurich
| 6 years |
| Marc Weber | M | 53 |
University of Zurich
| 7 years |
| Cédric Perlet | M | - |
University of Zurich
| 7 years |
| Thomas Roland Meier | M | 61 |
University of Zurich
| 4 years |
| Christian Hasler | M | - |
University of Zurich
| 5 years |
| Marcel Huber | M | - |
University of Zurich
| 6 years |
| Jakob Höhn | M | 64 |
University of Zurich
| 3 years |
| Martin Eisenring | M | - |
University of Zurich
| 3 years |
| Mathias Schmid | M | 60 |
University of Zurich
| 3 years |
| Peter-Mark Vogel | M | 58 |
University of Zurich
| 4 years |
| Dimitri Papadopoulos | M | - |
University of Zurich
| 3 years |
| Beat Buehlmann | M | 56 |
University of Zurich
| 3 years |
| Sven Zimmermann | M | 53 |
University of Zurich
| 3 years |
| Patrick Frost | M | 56 |
University of Zurich
| 3 years |
| Nic Dreckmann | M | 50 |
University of Zurich
| 4 years |
| Marija Zecevic | M | 51 |
University of Zurich
| 5 years |
| Sven Schaltegger | M | - |
University of Zurich
| 7 years |
| Ralph Mogicato | M | 61 |
University of Zurich
| 3 years |
| David P. Frick | M | 59 |
University of Zurich
| 5 years |
| Morten Holm Pedersen | M | - |
University of Zurich
| 2 years |
| Reto Schnabel | M | - |
University of Zurich
| 4 years |
| Tobias Guldimann | M | 62 |
University of Zurich
| 3 years |
| Markus Heusler | M | 65 |
University of Zurich
| 4 years |
| Ruedi Noser | M | 63 |
University of Zurich
| 4 years |
| Tobias Foster | M | 49 |
University of Zurich
| 4 years |
| Christian Kopfli | M | 58 |
University of Zurich
| 3 years |
| Wolfgang Zürcher | M | 59 |
University of Zurich
| 4 years |
| Philippe Schenk | M | - |
University of Zurich
| 3 years |
| Andreas Schulthess | M | 54 |
University of Zurich
| 4 years |
| Felix R. Ehrat | M | 67 |
University of Zurich
| 3 years |
| Markus Meier | M | 59 |
University of Zurich
| 4 years |
| Markus Kast | M | 54 |
Boston Consulting Group Holding AG
 Boston Consulting Group Holding AG MiscellaneousMiscellaneous Part of The Boston Consulting Group, Inc., Boston Consulting Group Holding AG operates as a holding Swiss company. The company is based in Zurich, Switzerland. Founded in 1963. | 2 years |
| Hans Baumgartner | M | 70 |
University of Zurich
| 3 years |
| Thomas Moser | M | 57 |
University of Zurich
| 3 years |
| Rajamannar Thennati | M | 63 |
University of Zurich
| 2 years |
| Stephan Naef | M | 62 |
University of Zurich
| 4 years |
| Michael Schulz | M | - |
University of Zurich
| 4 years |
| Hans Grüter | M | 65 |
University of Zurich
| 3 years |
| Christoph Lengwiler | M | 65 |
University of Zurich
| 6 years |
| Daniel Anders | M | 54 |
University of Zurich
| 4 years |
| Catrina Luchsinger Gähwiler | M | - |
University of Zurich
| 3 years |
| Georg Wohlwend | M | 61 |
University of Zurich
| 7 years |
| Jürg Sturzenegger | M | 63 |
University of Zurich
| 2 years |
| Patrick Schildknecht | M | 52 |
University of Zurich
| 4 years |
| Johannes Suter | M | - |
University of Zurich
| 5 years |
| Nicola C. Port | F | - |
University of Zurich
| 3 years |
| Markus Fromherz | M | - |
University of Zurich
| 3 years |
| Rudolf Marty | M | 75 |
University of Zurich
| 10 years |
| Dieter Spälti | M | 63 |
University of Zurich
| 3 years |
| Marcel Kucher | M | 53 |
University of Zurich
| 4 years |
| Christian Wiesendanger | M | 60 |
University of Zurich
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Sidler
- Personal Network
